Combination Chemotherapy for Solid Tumors in Head and Neck
نویسندگان
چکیده
منابع مشابه
Head and Neck Tumors: Management of Primary Undifferentiated Pleomorphic Sarcoma
Introduction: Sarcomas account for 1% of all tumors originated in the head and neck regions in adults. They constitute a heterogeneous group of tumors of mesenchymal origin with multiple histological variants. The undifferentiated pleomorphic sarcoma (UPS) subtype is the most frequent variant with an incidence range of 2.7-38%. Materials and Methods: This retrospective...
متن کاملHead and neck tumors
In 2003, it is estimated that head and neck cancers will comprise 2%-3% of all cancers in the United States and account for 1%-2% of all cancer deaths. This total includes 19,400 cases of oral cavity cancers, 9,500 cases of laryngeal cancer, and 8,300 cases of pharyngeal cancer. Most patients with head and neck cancer have metastatic disease at the time of diagnosis (regional nodal involvement ...
متن کاملReview of Oral and Dental Consideration in the Patients with Head and Neck Radiotherapy and Chemotherapy
Objectives Aggressive cancer therapy places patients at a greater risk for oral complications. Cancer patients suffer from oral toxic effects secondary to antineoplastic therapy (radiotherapy and chemotherapy). The aim of this review is management of the head and neck cancer patients that specifically emphasizes the prevention and treatment of oral and dental complications associated with c...
متن کاملA Review on the Efficacy of Chemotherapy in Locally Advanced Head and Neck Cancers
Background and Aims: Chemotherapy is utilized as a part of combined-modality programs to achieve organ preservation and improve survival in patients with locally advanced head and neck cancer. Combinedmodality protocols can be used in three forms: a) neoadjuvant induction chemotherapy before definitive surgery or radiotherapy; b) concomitant chemoradiotherapy; and c) sequential therapy consisti...
متن کاملChemotherapy for head and neck cancer.
Numerous studies have shown cisplatin-based chemotherapy to be effective in the treatment of head and neck cancer. Cisplatin/5-fluorouracil (5-FU) is the most frequently used combination regimen, but neurotoxicity, ototoxicity, and renal toxicity limit repeated dosing (for long-term treatment of responding patients) and dose intensification. In studies to date, the analogue carboplatin appears ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Drug Metabolism & Toxicology
سال: 2012
ISSN: 2157-7609
DOI: 10.4172/2157-7609.1000141